These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment. Zhou L; Matsushima GK Int Rev Cell Mol Biol; 2021; 361():165-210. PubMed ID: 34074493 [TBL] [Abstract][Full Text] [Related]
10. Mertk Interacts with Tim-4 to Enhance Tim-4-Mediated Efferocytosis. Moon B; Lee J; Lee SA; Min C; Moon H; Kim D; Yang S; Moon H; Jeon J; Joo YE; Park D Cells; 2020 Jul; 9(7):. PubMed ID: 32640697 [TBL] [Abstract][Full Text] [Related]
11. Two-step engulfment of apoptotic cells. Toda S; Hanayama R; Nagata S Mol Cell Biol; 2012 Jan; 32(1):118-25. PubMed ID: 22037761 [TBL] [Abstract][Full Text] [Related]
12. The receptor tyrosine kinase MerTK activates phospholipase C gamma2 during recognition of apoptotic thymocytes by murine macrophages. Todt JC; Hu B; Curtis JL J Leukoc Biol; 2004 Apr; 75(4):705-13. PubMed ID: 14704368 [TBL] [Abstract][Full Text] [Related]
13. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804 [TBL] [Abstract][Full Text] [Related]
14. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Myers KV; Amend SR; Pienta KJ Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471 [TBL] [Abstract][Full Text] [Related]
15. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers. Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409 [TBL] [Abstract][Full Text] [Related]
16. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders. Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V Front Immunol; 2023; 14():1135373. PubMed ID: 37545504 [TBL] [Abstract][Full Text] [Related]
18. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G Elife; 2014 Sep; 3():. PubMed ID: 25265470 [TBL] [Abstract][Full Text] [Related]
19. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795 [TBL] [Abstract][Full Text] [Related]
20. Identification of Tim4 as a phosphatidylserine receptor. Miyanishi M; Tada K; Koike M; Uchiyama Y; Kitamura T; Nagata S Nature; 2007 Nov; 450(7168):435-9. PubMed ID: 17960135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]